Nanobac Pharmaceuticals, Incorporated (NNBP)

Nanobac Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Revenue	0.02	0.23	0.66	0.36	0.48
Revenue Growth (YoY)	-92.17%	-65.73%	83.28%	-25.78%	-
Cost of Revenue	0.01	0.08	0.23	0.1	0.33
Gross Profit	0	0.15	0.43	0.26	0.15
Selling, General & Admin	2.83	1.84	1.31	4.89	2.13
Research & Development	1.15	1.99	1.19	2.25	0.54
Operating Expenses	4.44	4.37	3.27	7.86	2.85
Operating Income	-4.43	-4.23	-2.84	-7.6	-2.7
Interest Expense	-0.19	-0.2	-0.07	-0.25	-0.04
Currency Exchange Gain (Loss)	0.09	0.05	-0.04	-	-
Other Non Operating Income (Expenses)	0	0	-0.74	-0.61	-0.02
EBT Excluding Unusual Items	-4.54	-4.37	-3.69	-8.46	-2.76
Gain (Loss) on Sale of Assets	-	-0.02	-	-	-
Asset Writedown	-	-0.59	-	-	-
Legal Settlements	-0.48	-	-	-	-
Other Unusual Items	-1.56	-	-	-	-
Pretax Income	-6.58	-4.97	-3.69	-8.46	-2.76
Earnings From Continuing Operations	-6.58	-4.97	-3.69	-8.46	-2.76
Earnings From Discontinued Operations	-	-	-	-0.06	-0.94
Net Income	-6.58	-4.97	-3.69	-8.52	-3.7
Net Income to Common	-6.58	-4.97	-3.69	-8.52	-3.7
Shares Outstanding (Basic)	245	199	191	153	67
Shares Outstanding (Diluted)	245	199	191	153	67
Shares Change (YoY)	22.95%	4.62%	24.67%	126.56%	384.10%
EPS (Basic)	-0.03	-0.02	-0.02	-0.06	-0.05
EPS (Diluted)	-0.03	-0.02	-0.02	-0.06	-0.05
Free Cash Flow	-0.91	-2.6	-2.41	-3.43	-2.17
Free Cash Flow Per Share	-0.00	-0.01	-0.01	-0.02	-0.03
Gross Margin	17.60%	64.55%	65.07%	71.96%	31.00%
Operating Margin	-25162.08%	-1879.07%	-432.05%	-2120.87%	-559.26%
Profit Margin	-37319.74%	-2209.53%	-561.41%	-2377.05%	-766.23%
Free Cash Flow Margin	-5178.02%	-1154.07%	-366.31%	-957.84%	-450.17%
EBITDA	-3.97	-3.69	-2.08	-6.88	-2.52
D&A For EBITDA	0.46	0.54	0.76	0.72	0.18
EBIT	-4.43	-4.23	-2.84	-7.6	-2.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.